CNO Financial Group (CNO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Executive summary
Achieved strong financial and operational results in 2025, with net income of $229.3 million and net operating income of $439.2 million, driven by sales growth, improved margins, and disciplined expense management.
Returned $386.1 million to shareholders through share repurchases and dividends, reducing share count by 8% and maintaining robust capital and liquidity positions.
Continued strategic transformation, including exiting Worksite fee services and focusing on core insurance business, while maintaining a diversified distribution model.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors for one-year terms, a non-binding advisory vote on executive compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
Proxy access and advance notice provisions are in place for shareholder proposals and director nominations for future meetings.
Board of directors and corporate governance
Board comprises 90% independent directors, with diverse backgrounds in gender, ethnicity, and professional experience.
Five board committees oversee audit, governance, compensation, investment, and executive matters, each with defined charters and responsibilities.
Regular board refreshment and succession planning, with five new directors in the past five years and robust onboarding and evaluation processes.
Board leadership structure features an independent chair, separate from the CEO.
Latest events from CNO Financial Group
- Annual meeting covers director elections, executive pay, auditor ratification, and ESG efforts.CNO
Proxy filing26 Mar 2026 - Record premiums, 11% EPS growth, and strong capital returns highlight robust 2025 results.CNO
Q4 20256 Feb 2026 - Operating EPS up 94%, guidance raised, and strong growth in sales and agent productivity.CNO
Q2 20242 Feb 2026 - Growth momentum driven by middle market focus, agent productivity, and operational efficiency.CNO
2024 KBW Insurance Conference22 Jan 2026 - Operating earnings and annuity sales surged, prompting raised 2024 guidance and strong capital returns.CNO
Q3 202417 Jan 2026 - Operating EPS up 52%, guidance reaffirmed, and capital strength and buybacks continued.CNO
Q1 202524 Dec 2025 - Record earnings, sales, and capital returns in 2024, with strong ROE and growth outlook.CNO
Q4 202422 Dec 2025 - Record financial performance, robust governance, and key plan amendments drive 2025 proxy agenda.CNO
Proxy Filing1 Dec 2025 - Record financial results, increased shareholder returns, and key governance votes mark 2025's agenda.CNO
Proxy Filing1 Dec 2025